Another limitation of GLP-1 RAs is that discontinuation commonly leads to substantial body weight regain, and many patients who regain weight subsequently restart GLP-1 RA therapy, resulting in a recurrent cycle of body weight loss and gain [10]
This fat covering the surface of the heart appears to be a source of inflammatory factors that can directly affect the heart muscle
Study findings revealed that once-weekly subcutaneous semaglutide showed the largest estimated effect on body weight and several metabolic markers, identifying the GLP-1 RA as a highly promising intervention for future clinical trials in psychiatric populations, although comparative rankings remain uncertain because the evidence base was small, heterogeneous, and largely indirect
We gratefully acknowledge assistance from the UNSW Biological Resource Centre and Tzong-Tyng Hung from the Biological Resource Imaging Laboratory (BRIL) of the Mark Wainwright Analytical Centre, UNSW, which is a member of the National Imaging Facility, and the Bioanalytical Mass Spectrometry Facility of the Mark Wainwright Analytical Centre at UNSW
Compounded tirzepatide is tirzepatide prepared by a licensed compounding pharmacy
Dehydration hardens stool and makes constipation worse
